Offer - Urjas Oil for just ₹ 1 X
Silofast D 4 Combipack, a prescription drug, is manufactured in various forms such as Capsule. Secondary and off-label uses of Silofast D 4 Combipack have also been mentioned below.
The correct dosage of Silofast D 4 Combipack depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Silofast D 4 Combipack can also lead to other problems, which have been listed below. Such side effects of Silofast D 4 Combipack normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Silofast D 4 Combipack is Severe for pregnant women and Severe for women who are breastfeeding. It is important to know if Silofast D 4 Combipack has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Silofast D 4 Combipack related warnings section.
Silofast D 4 Combipack is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease, Liver Disease are examples of such conditions. Other conditions have been mentioned below in the Silofast D 4 Combipack contraindications section.
Besides this, Silofast D 4 Combipack may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to the above precautions for Silofast D 4 Combipack, it is important to know that it is safe while driving, and is habit-forming.
Silofast D 4 Combipack is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Male) |
|
Geriatric |
|
Is the use of Silofast D 4 Combipack safe for pregnant women?
Silofast D should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Silofast D 4 Combipack safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Silofast D. It should only be taken after medical advice.
What is the effect of Silofast D 4 Combipack on the Kidneys?
Silofast D does not damage the kidneys.
What is the effect of Silofast D 4 Combipack on the Liver?
Silofast D can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Silofast D 4 Combipack on the Heart?
Silofast D is not harmful for the heart.
Silofast D 4 Combipack should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Silofast D 4 Combipack unless your doctor advises you to do so -
Is this Silofast D 4 Combipack habit forming or addictive?
Silofast D 4 Combipack does not cause addiction.
Interaction between Food and Silofast D 4 Combipack
Due to the absence of research, it is difficult to say how Silofast D 4 Combipack and food will interact.
Interaction between Alcohol and Silofast D 4 Combipack
Due to lack of research, there is no information about the side effects of taking Silofast D 4 Combipack with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rapaflo® (silodosin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1137-1138
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 476-477
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 303
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avodart® (dutasteride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jalyn (dutasteride and tamsulosin hydrochloride)